Two Sigma Securities’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,820
Closed -$225K 2357
2019
Q3
$225K Sell
4,820
-3,775
-44% -$176K ﹤0.01% 1771
2019
Q2
$449K Buy
+8,595
New +$504K ﹤0.01% 1187
2018
Q3
Sell
-7,232
Closed -$816K 2625
2018
Q2
$913K Buy
7,232
+1,421
+24% +$173K ﹤0.01% 1400
2018
Q1
$629K Buy
+5,811
New +$643K ﹤0.01% 1521
2017
Q3
Sell
-4,719
Closed -$478K 957
2017
Q2
$478K Buy
+4,719
New +$509K 0.09% 212

Other funds holding CLB

Two Sigma Securities's CLB Position: Q4 2019 in Review

Two Sigma Securities sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 4,820 shares — an estimated $225K sold.

Two Sigma Securities first reported a position in CLB in Q2 2017 and held it in 5 quarters. The position peaked at $913K in Q2 2018. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • Two Sigma Securities reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Securities sold 4,820 Core Laboratories shares in Q4 2019, an estimated $225K.
  • Two Sigma Securities first reported a position in Core Laboratories in Q2 2017 and held it in 5 quarters.
  • Two Sigma Securities's Core Laboratories position peaked at $913K in Q2 2018.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Two Sigma Securities's 13F filing for Q4 2019, filed 14 Feb 2020.